Please login to the form below

Not currently logged in
Email:
Password:

Boehringer appoints new chairman of the board

Hubertus vonBaumbach will succeed Andreas Barner
Hubert von Baumbach

Boehringer Ingelheim has appointed Hubertus von Baumbach as chairman of the board of managing directors with effect from June 2016.

Baumbach has been a member of the board of managing directors since 2009 and is head of the corporate board division of finance. He has also worked at Roche in the US and at Boehringer Ingelheim in Canada.

His appointment follows the move of the current chair, Andreas Barner, to the shareholders' committee.

Christian Boehringer, chair of the shareholders' committee, said: “This decision provided a successor who would ensure continuity whilst also looking to the future. Hubertus von Baumbach knows the corporation and its various divisions and his time on the board of managing directors has prepared him well for the company's future challenges.   

"Along with colleagues on the board of managing directors, he will continue the drive for change at Boehringer Ingelheim in order to secure the company's independence in the long term.”  

Also joining the board is Michel Pairet who will be responsible for the corporate business division of research and nonclinical development from January 1 2016. He formerly led the pharmacology unit at the research facility in Biberach

Article by
Nikhil Patel

9th November 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics